Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemcheck has developed and commercialized the Helge system—a CE-marked point-of-care diagnostic platform that rapidly detects and quantifies hemolysis in whole blood samples. The system improves patient safety by ensuring only high-quality blood samples are analyzed. Clinical feedback from studies such as those at Liverpool Heart and Chest Hospital has been positive. The company recently announced plans to acquire IP rights related to iron succinate treatment for heart failure from Bio Vitos. No clinical trial results are relevant as this is a diagnostic/device platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemcheck.